Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Rossignol

Showing results (61-70 of 135) with videos related to

Pageof 14
Sort By:
Brain Sciences|February 26, 2025
Sex and Strain-Specific Variations in Motor Recovery Following Compression Spinal Cord Injury: Comparison of Sprague-Dawley and Wistar RatsNegin Mojarad, David Doyle, Lucas Gorial Garmo, et al.
Journal of Neuroscience Methods|June 21, 2018
Behavioral and neurochemical responses derived from dopaminergic intrastriatal grafts in hemiparkinsonian rats engaged in a novel motor taskParnit K Bhupal, Kevin A Anderson, Gabrielle P Shall, et al.
Stem Cells (Dayton, Ohio)|August 14, 2013
Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of Huntington's diseaseJulien Rossignol, Kyle Fink, Kendra Davis, et al.
Cell Transplantation|February 7, 2016
Mesenchymal Stem Cells as Treatment for Behavioral Deficits and Neuropathology in the 5xFAD Mouse Model of Alzheimer's DiseaseJessica J Matchynski-Franks, Colleen Pappas, Julien Rossignol, et al.
Blood Cells, Molecules & Diseases|December 4, 2019
Mastocytosis onset in a patient with treated hairy cell leukemia: Just a coincidence?Alice Boilève, Adrien Contejean, Sylvain Barreau, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 5, 2020
Outcomes of Transplant-Eligible Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Salvage Chemotherapy: The Gustave Roussy ExperienceElie Rassy, Alina Danu, Toni Ibrahim, et al.
Frontiers in Medicine|December 5, 2022
BLNK mutation associated with T-cell LGL leukemia and autoimmune diseases: Case report in hematologyGuillemette Fouquet, Julien Rossignol, Laure Ricard, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 18, 2020
Criteria for the Regression of Pediatric Mastocytosis: A Long-Term Follow-UpLaura Polivka, Julien Rossignol, Antoine Neuraz, et al.
Behavioural Brain Research|May 25, 2010
Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's diseaseNicholas D Dey, Matthew C Bombard, Bartholomew P Roland, et al.
Restorative Neurology and Neuroscience|June 10, 2017
SDF-1 overexpression by mesenchymal stem cells enhances GAP-43-positive axonal growth following spinal cord injuryAndrew Nathaniel Stewart, Jessica Jane Matyas, Ryan Matthew Welchko, et al.
Pageof 14

Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
Brain Sciences|February 26, 2025
Sex and Strain-Specific Variations in Motor Recovery Following Compression Spinal Cord Injury: Comparison of Sprague-Dawley and Wistar RatsNegin Mojarad, David Doyle, Lucas Gorial Garmo, et al.
Journal of Neuroscience Methods|June 21, 2018
Behavioral and neurochemical responses derived from dopaminergic intrastriatal grafts in hemiparkinsonian rats engaged in a novel motor taskParnit K Bhupal, Kevin A Anderson, Gabrielle P Shall, et al.
Stem Cells (Dayton, Ohio)|August 14, 2013
Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of Huntington's diseaseJulien Rossignol, Kyle Fink, Kendra Davis, et al.
Cell Transplantation|February 7, 2016
Mesenchymal Stem Cells as Treatment for Behavioral Deficits and Neuropathology in the 5xFAD Mouse Model of Alzheimer's DiseaseJessica J Matchynski-Franks, Colleen Pappas, Julien Rossignol, et al.
Blood Cells, Molecules & Diseases|December 4, 2019
Mastocytosis onset in a patient with treated hairy cell leukemia: Just a coincidence?Alice Boilève, Adrien Contejean, Sylvain Barreau, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 5, 2020
Outcomes of Transplant-Eligible Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Salvage Chemotherapy: The Gustave Roussy ExperienceElie Rassy, Alina Danu, Toni Ibrahim, et al.
Frontiers in Medicine|December 5, 2022
BLNK mutation associated with T-cell LGL leukemia and autoimmune diseases: Case report in hematologyGuillemette Fouquet, Julien Rossignol, Laure Ricard, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 18, 2020
Criteria for the Regression of Pediatric Mastocytosis: A Long-Term Follow-UpLaura Polivka, Julien Rossignol, Antoine Neuraz, et al.
Behavioural Brain Research|May 25, 2010
Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's diseaseNicholas D Dey, Matthew C Bombard, Bartholomew P Roland, et al.
Restorative Neurology and Neuroscience|June 10, 2017
SDF-1 overexpression by mesenchymal stem cells enhances GAP-43-positive axonal growth following spinal cord injuryAndrew Nathaniel Stewart, Jessica Jane Matyas, Ryan Matthew Welchko, et al.
Pageof 14